Hobbs Brian D, Parker Margaret M, Chen Han, Lao Taotao, Hardin Megan, Qiao Dandi, Hawrylkiewicz Iwona, Sliwinski Pawel, Yim Jae-Joon, Kim Woo Jin, Kim Deog Kyeom, Castaldi Peter J, Hersh Craig P, Morrow Jarrett, Celli Bartolome R, Pinto-Plata Victor M, Criner Gerald J, Marchetti Nathaniel, Bueno Raphael, Agustí Alvar, Make Barry J, Crapo James D, Calverley Peter M, Donner Claudio F, Lomas David A, Wouters Emiel F M, Vestbo Jorgen, Paré Peter D, Levy Robert D, Rennard Stephen I, Zhou Xiaobo, Laird Nan M, Lin Xihong, Beaty Terri H, Silverman Edwin K, Cho Michael H
1 Channing Division of Network Medicine.
2 Division of Pulmonary and Critical Care Medicine.
Am J Respir Crit Care Med. 2016 Jul 1;194(1):48-57. doi: 10.1164/rccm.201510-2053OC.
Chronic obstructive pulmonary disease (COPD) susceptibility is in part related to genetic variants. Most genetic studies have been focused on genome-wide common variants without a specific focus on coding variants, but common and rare coding variants may also affect COPD susceptibility.
To identify coding variants associated with COPD.
We tested nonsynonymous, splice, and stop variants derived from the Illumina HumanExome array for association with COPD in five study populations enriched for COPD. We evaluated single variants with a minor allele frequency greater than 0.5% using logistic regression. Results were combined using a fixed effects meta-analysis. We replicated novel single-variant associations in three additional COPD cohorts.
We included 6,004 control subjects and 6,161 COPD cases across five cohorts for analysis. Our top result was rs16969968 (P = 1.7 × 10(-14)) in CHRNA5, a locus previously associated with COPD susceptibility and nicotine dependence. Additional top results were found in AGER, MMP3, and SERPINA1. A nonsynonymous variant, rs181206, in IL27 (P = 4.7 × 10(-6)) was just below the level of exome-wide significance but attained exome-wide significance (P = 5.7 × 10(-8)) when combined with results from other cohorts. Gene expression datasets revealed an association of rs181206 and the surrounding locus with expression of multiple genes; several were differentially expressed in COPD lung tissue, including TUFM.
In an exome array analysis of COPD, we identified nonsynonymous variants at previously described loci and a novel exome-wide significant variant in IL27. This variant is at a locus previously described in genome-wide associations with diabetes, inflammatory bowel disease, and obesity and appears to affect genes potentially related to COPD pathogenesis.
慢性阻塞性肺疾病(COPD)易感性部分与基因变异有关。大多数基因研究集中于全基因组常见变异,未特别关注编码变异,但常见和罕见编码变异也可能影响COPD易感性。
鉴定与COPD相关的编码变异。
我们在五个富含COPD的研究人群中,测试了来自Illumina HumanExome阵列的非同义、剪接和终止变异与COPD的关联性。我们使用逻辑回归评估次要等位基因频率大于0.5%的单个变异。结果通过固定效应荟萃分析进行合并。我们在另外三个COPD队列中重复了新的单变异关联。
我们纳入了五个队列中的6004名对照受试者和6161例COPD病例进行分析。我们的首要结果是CHRNA5基因中的rs16969968(P = 1.7×10⁻¹⁴),该位点先前与COPD易感性和尼古丁依赖有关。在AGER、MMP3和SERPINA1基因中也发现了其他首要结果。IL27基因中的一个非同义变异rs181206(P = 4.7×10⁻⁶)略低于外显子组水平的显著性,但与其他队列的结果合并后达到了外显子组水平的显著性(P = 5.7×10⁻⁸)。基因表达数据集显示rs181206及其周围位点与多个基因的表达相关;其中一些基因在COPD肺组织中差异表达,包括TUFM。
在对COPD的外显子阵列分析中,我们在先前描述的位点鉴定出非同义变异,并在IL27基因中发现了一个新的外显子组水平显著变异。该变异位于先前在全基因组关联研究中与糖尿病、炎症性肠病和肥胖相关的位点,似乎影响了可能与COPD发病机制相关的基因。